Metamark Genetics, Inc. Names Dr. Peter Maimonis As Senior Vice President And Chief Science Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metamark Genetics, Inc. ("Metamark" or the "Company"), a leader in commercializing high value urologic oncology products, announced today that Peter Maimonis, Ph.D., has joined Metamark's leadership team as Senior Vice President and Chief Science Officer, effective October 7, 2015.